Emerging Trends in Cold Storage Solutions
Qualistery
Empowering Pharma through Knowledge and Connections for Compliance, Informed Decision-Making and Innovation.
Welcome back to the Weekly Savvy GMP Newsletter, your go-to resource for navigating the dynamic landscape of the pharmaceutical industry. In this ?edition,?we are excited to share insights from the recent CPHI Milan event, where Scott Masiella from FARRAR discussed the evolving landscape of cold storage solutions in the life sciences and pharmaceutical sectors.
?
Rising Demand for Ultra-Low Temperature Solutions
During an insightful interview with Yan Kugel from Qualistery, Scott highlighted the increasing requirement for ultra-low temperature (ULT) processes. The pharmaceutical industry is witnessing a surge in diverse temperature needs, including refrigerated temperatures around -70°C to -80°C and newer applications demanding -30°C to -50°C for proteins and APIs. This trend emphasizes the necessity for flexibility in temperature management across various pharmaceutical products. FARRAR is addressing this need by developing adaptable equipment for multiple temperature applications, maximizing utility and efficiency.
?
Commitment to Sustainability
Sustainability is becoming a crucial focus in the pharmaceutical industry. FARRAR is leading the charge by utilizing low global warming potential (GWP) refrigerants and prioritizing energy efficiency. By aligning with regulatory expectations and addressing consumer demand for sustainable practices, FARRAR is setting an example for the industry.
Streamlining Processes with Advanced Technology
FARRAR is committed to leveraging advanced technologies to enhance efficiency and reliability in cold storage. Their innovative 4-Stair Technology exemplifies this commitment, ensuring high yield production while maintaining compliance with industry standards.
?
领英推荐
Strategic Partnerships for Tailored Solutions
Collaboration is key to success in the pharmaceutical landscape. FARRAR thrives on building strategic partnerships with clients, focusing on customized material handling solutions, specialized freezing techniques, and ensuring regulatory compliance. These partnerships not only drive innovation but also strengthen trust in FARRAR’s commitment to quality and reliability.
?
Upcoming Innovations and Future Goals
FARRAR is poised to launch new products enhancing cold storage capabilities, particularly for smaller batch productions such as oncology drugs and orphan drugs. Their strategic focus includes engaging customers throughout the product lifecycle and exploring quicker maintenance options to minimize production downtime. By staying connected with clients, FARRAR is well-positioned to meet the dynamic needs of the pharmaceutical sector.
?
Conclusion
Scott Masiella's insights at CPHI Milan highlight FARRAR’s pivotal role in shaping the future of cold storage solutions in the life sciences industry. With a steadfast commitment to innovation, sustainability, and collaboration, FARRAR is setting new standards for excellence in pharmaceutical storage solutions.
?
Want to know more about the interview? Read the entire article and watch the YouTube video here:?
?
AM sterile #Ex Barret Hodgson #Ex Searle #Macter#Ex pharmatec
4 个月Great advice
GXP Expert takes your processes and tasks in pharmacovigilance, clinical trials and GMP / GDP to the next level. We support the pharmaceutical industry with the highest quality standards.
4 个月Guter Tipp!